VIKING GLOBAL INVESTORS LP
STAMFORD, CT · CIK 0001103804
Portfolio Value: $23.84B
Positions: 60
Period: 2014-03-31
Filed: 2014-05-15
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020Q2 2020Q1 2020Q4 2019Q3 2019Q2 2019Q1 2019Q4 2018Q3 2018Q2 2018Q1 2018Q4 2017Q3 2017Q2 2017Q1 2017Q4 2016Q3 2016Q2 2016Q1 2016Q4 2015Q3 2015Q2 2015Q1 2015Q4 2014Q3 2014Q2 2014Q1 2014Q4 2013Q3 2013Q2 2013
Portfolio Value
$23.84B
Positions
60
New
17
Increased
26
Decreased
17
Sold Out
67
VIKING GLOBAL INVESTORS LP Q1 2014 13F Filing Summary
VIKING GLOBAL INVESTORS LP (STAMFORD, CT) reported a portfolio value of $23.84B across 60 positions in their Q1 2014 SEC 13F filing (period ending 2014-03-31). Top holdings include WBA ($1.59B), TWXCHF ($1.41B), ILMN ($1.32B). The top 10 positions account for 48.0% of the portfolio. This quarter saw 17 new positions, 26 increases, 17 reductions, 67 complete exits. Notable new buys: REGN ($315.83M), IONR ($306.45M), ADSK ($281.88M). Notable exits: CX, SIRI, DHR.
All Holdings
Showing 1-50 of 60
Position Changes
| Stock | Value | Shares |
|---|---|---|
REGNREGENERON PHARMACEUTICALS | $315.83M | 1,051,800 |
IONRPIONEER NAT RES CO | $306.45M | 1,637,536 |
ADSKAUTODESK INC | $281.88M | 5,731,636 |
SOKANSAS CITY SOUTHERN | $187.55M | 1,837,625 |
SALIX PHARMACEUTICALS INC | $160.78M | 1,551,766 |
INTRINTERCEPT PHARMACEUTICALS IN | $150.03M | 454,917 |
USBUS BANCORP DEL | $148.68M | 3,469,000 |
ZNGAEURZYNGA INC | $122.35M | 28,452,470 |
MYLAN INC | $86.73M | 1,776,108 |
ING U S INC | $66.51M | 1,833,700 |
STHONORTHSTAR RLTY FIN CORP | $58.34M | 3,614,560 |
NXPINXP SEMICONDUCTORS N V | $52.53M | 893,200 |
CMECME GROUP INC | $41.33M | 558,300 |
STTSTATE STR CORP | $40.09M | 576,394 |
HPHELMERICH & PAYNE INC | $32.17M | 299,100 |
HNOIQIHOO 360 TECHNOLOGY CO LTD | $32.05M | 321,900 |
CTXSEURCITRIX SYS INC | $10.34M | 180,000 |